ProCE Banner Activity

Studies 1489 and 1490: Metabolic Complications at 3 Yr With First-line BIC/FTC/TAF, DTG/ABC/3TC, or DTG + FTC/TAF Among PWH

Slideset Download
Conference Coverage
Data showed increases in BMI in all groups but no marked differences between regimens at Week 144 for treatment-emergent diabetes or hypertension or for changes in BMI.

Released: October 03, 2021

Expiration: October 02, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Ferring Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare